Novel possibilities of antithrombotic therapy in patients with chronic heart failure

被引：0
|
作者：
Olbinskaya, LI [1 ]
Kolosova, K [1 ]
Nesterova, SG [1 ]
Egorova, TD [1 ]
Fedorova, AY [1 ]
机构：
[1] IM Sechenov Med Acad, Moscow 119881, Russia
来源：
KARDIOLOGIYA | 2005年 / 45卷 / 12期
关键词：
thrombosis; thromboembolism; venous; heart failure; chronic; enoxaparin;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Modern approaches to prevention of venous thromboembolic complications in patients with chronic heart failure are analyzed in this review which contains results of large studies of low molecular weight heparins. In MEDENOX trial the use of enoxaparin in medical patients was associated with 63% reduction of risk of thrombosis. The authors own experience showed that 2 weeks of therapy with enoxaparin in patients with chronic stage IIB-III heart failure caused significant lowering of soluble fibrin-monomer complexes, fibrinogen, and index of turbodynamic potential. These changes evidenced for decreased intravascular blood coagulation. Thus enoxaparin can be effectively used for prevention of thrombosis and thromboembolism in patients with chronic heart failure. Novel antithrombotic agents fondaparinux, idraparinux, ximelagatran, recombinant thrombomodulin are perspective medications for prevention of venous thromboses and embolism in medical patients.
引用
收藏
页码：93 / 98
页数：6
相关论文
共 50 条
  • [21] Adherence to therapy in patients with chronic heart failure
    Efremova, E. V. Elena
    Shutov, A. M.
    Shevchenko, S. V.
    Kortunova, M. J. U.
    Lyukshonkova, K. A.
    Semyonova, E. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 241 - 241
  • [22] Waon therapy in patients with chronic heart failure
    Kihara, Takashi
    Tei, Chuwa
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (07) : S139 - S139
  • [23] Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure
    Nochioka, Kotaro
    Yasuda, Satoshi
    Sakata, Yasuhiko
    Shiroto, Takashi
    Hayashi, Hideka
    Takahashi, Jun
    Takahama, Hiroyuki
    Miyata, Satoshi
    Shimokawa, Hiroaki
    ESC HEART FAILURE, 2022, 9 (04): : 2445 - 2454
  • [24] Possibilities of Ultrasound Diagnosis of Sarcopenia in Elderly Patients with Chronic Heart Failure
    N. I. Gulyaev
    I. M. Akhmetshin
    A. V. Gordienco
    A. N. Kulikov
    Advances in Gerontology, 2020, 10 : 182 - 186
  • [25] Possibilities of myocardial cytoprotection in complex treatment of patients with chronic heart failure
    Vasyuk, Yu. A.
    Yushchuk, E. N.
    Shkolnik, E. L.
    Khadzegova, A. B.
    Vitko, N. K.
    Vakhromeeva, M. N.
    KARDIOLOGIYA, 2006, 46 (11) : 48 - 56
  • [26] Possibilities of Ultrasound Diagnosis of Sarcopenia in Elderly Patients with Chronic Heart Failure
    Gulyaev, N., I
    Akhmetshin, I. M.
    Gordienco, A., V
    Kulikov, A. N.
    ADVANCES IN GERONTOLOGY, 2020, 10 (02) : 182 - 186
  • [27] Is antithrombotic therapy a risk-free and beneficial treatment for patients with heart failure?
    Verheugt, Freek W. A.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2004, 1 (02): : 80 - 81
  • [28] Is antithrombotic therapy a risk-free and beneficial treatment for patients with heart failure?
    Freek WA Verheugt
    Nature Clinical Practice Cardiovascular Medicine, 2004, 1 : 80 - 81
  • [29] Antithrombotic therapy in heart failure and sinus rhythm: the ongoing search for a better match of patients to therapy
    Fabris, Enrico
    Sinagra, Gianfranco
    Valgimigli, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) : 657 - 660
  • [30] Antithrombotic Therapy in Heart Failure-The Clot Thickens
    Konstam, Marvin A.
    JAMA CARDIOLOGY, 2019, 4 (06) : 524 - 525
12345